These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32193733)

  • 1. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Skrabal D; Tykalova T; Klempir J; Ruzicka E; Rusz J
    J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
    J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
    Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
    Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease.
    Kang K; Nunes AS; Sharma M; Hall AJ; Mishra RK; Casado J; Cole R; Derhammer M; Barchard G; Najafi B; Vaziri A; Wills AM; Pantelyat A
    Parkinsonism Relat Disord; 2023 Oct; 115():105835. PubMed ID: 37678101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Daoudi K; Das B; Tykalova T; Klempir J; Rusz J
    NPJ Parkinsons Dis; 2022 Oct; 8(1):142. PubMed ID: 36302780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parkinsonism-associated speech disorders].
    Skripkina NA; Arefyeva AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10. Vyp. 2):61-66. PubMed ID: 33205932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
    Miller N; Nath U; Noble E; Burn D
    Neurodegener Dis Manag; 2017 Jun; 7(3):191-203. PubMed ID: 28632098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Vowel Articulation Analysis in Connected Speech Among Progressive Neurological Diseases, Dysarthria Types, and Dysarthria Severities.
    Illner V; Tykalova T; Skrabal D; Klempir J; Rusz J
    J Speech Lang Hear Res; 2023 Aug; 66(8):2600-2621. PubMed ID: 37499137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
    Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
    Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posturographic abnormalities in ambulatory atypical parkinsonian disorders: Differentiating characteristics.
    Panyakaew P; Anan C; Bhidayasiri R
    Parkinsonism Relat Disord; 2019 Sep; 66():94-99. PubMed ID: 31337595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.